FDA Alerts
FDA Approves New Type of Sleep Medication
The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia).
FDA Warning: Counterfeit Adderall
The U.S. Food and Drug Administration is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets that is being purchased on the Internet.
Viibryd Approved for Major Depression
Viibryd has just been approved by the FDA to treat adults with major depression, a mental disorder which affects around 15 million people in the United States.